BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28993452)

  • 1. Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in
    Caroccia B; Prisco S; Seccia TM; Piazza M; Maiolino G; Rossi GP
    Hypertension; 2017 Dec; 70(6):1238-1242. PubMed ID: 28993452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTA1 Expression Is Correlated With Aldosterone Level in KCNJ5-Mutated Adrenal Aldosterone-Producing Adenoma.
    Li X; Wang B; Tang L; Zhang Y; Chen L; Gu L; Zhang F; Ouyang J; Zhang X
    J Clin Endocrinol Metab; 2018 Mar; 103(3):813-823. PubMed ID: 29165597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
    Cheng CJ; Sung CC; Wu ST; Lin YC; Sytwu HK; Huang CL; Lin SH
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E155-63. PubMed ID: 25347571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Cell Subtypes Based on the Intracellular Hormonal Activity in KCNJ5-Mutated Aldosterone-Producing Adenoma.
    Yamazaki Y; Omata K; Tezuka Y; Ono Y; Morimoto R; Adachi Y; Ise K; Nakamura Y; Gomez-Sanchez CE; Shibahara Y; Kitamoto T; Nishikawa T; Ito S; Satoh F; Sasano H
    Hypertension; 2018 Sep; 72(3):632-640. PubMed ID: 30354756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
    De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
    Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
    Taguchi R; Yamada M; Nakajima Y; Satoh T; Hashimoto K; Shibusawa N; Ozawa A; Okada S; Rokutanda N; Takata D; Koibuchi Y; Horiguchi J; Oyama T; Takeyoshi I; Mori M
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1311-9. PubMed ID: 22278422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
    Yamada M; Nakajima Y; Taguchi R; Okamura T; Ishii S; Tomaru T; Ozawa A; Shibusawa N; Yoshino S; Toki A; Ishida E; Hashimoto K; Satoh T; Mori M
    Endocr J; 2012; 59(8):735-41. PubMed ID: 22863749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
    Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
    Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolides selectively inhibit mutant KCNJ5 potassium channels that cause aldosterone-producing adenoma.
    Scholl UI; Abriola L; Zhang C; Reimer EN; Plummer M; Kazmierczak BI; Zhang J; Hoyer D; Merkel JS; Wang W; Lifton RP
    J Clin Invest; 2017 Jun; 127(7):2739-2750. PubMed ID: 28604387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
    Boulkroun S; Golib Dzib JF; Samson-Couterie B; Rosa FL; Rickard AJ; Meatchi T; Amar L; Benecke A; Zennaro MC
    Mol Cell Endocrinol; 2013 May; 371(1-2):221-7. PubMed ID: 23376008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of Aldosterone-Producing Adenoma in Korean Patients.
    Hong AR; Kim JH; Song YS; Lee KE; Seo SH; Seong MW; Shin CS; Kim SW; Kim SY
    PLoS One; 2016; 11(1):e0147590. PubMed ID: 26807823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Molecular Characterization of Aldosterone-Producing Adenomas in White Americans.
    Nanba K; Omata K; Else T; Beck PCC; Nanba AT; Turcu AF; Miller BS; Giordano TJ; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3869-3876. PubMed ID: 30085035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.
    Tezuka Y; Yamazaki Y; Kitada M; Morimoto R; Kudo M; Seiji K; Takase K; Kawasaki Y; Mitsuzuka K; Ito A; Nishikawa J; Asai N; Nakamura Y; Gomez-Sanchez CE; Ito S; Dezawa M; Sasano H; Satoh F
    Hypertension; 2019 Jun; 73(6):1283-1290. PubMed ID: 31006333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients.
    Nanba K; Yamazaki Y; Bick N; Onodera K; Tezuka Y; Omata K; Ono Y; Blinder AR; Tomlins SA; Rainey WE; Satoh F; Sasano H
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4066-73. PubMed ID: 32844168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
    Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
    PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
    Scholl UI; Lifton RP
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):141-7. PubMed ID: 23318698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
    Fernandes-Rosa FL; Williams TA; Riester A; Steichen O; Beuschlein F; Boulkroun S; Strom TM; Monticone S; Amar L; Meatchi T; Mantero F; Cicala MV; Quinkler M; Fallo F; Allolio B; Bernini G; Maccario M; Giacchetti G; Jeunemaitre X; Mulatero P; Reincke M; Zennaro MC
    Hypertension; 2014 Aug; 64(2):354-61. PubMed ID: 24866132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.